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Supervised exercise therapy for intermittent
claudication in daily practice
Lotte M. Kruidenier, MD,a Saskia P. Nicolaï, MD,a Erik J. Hendriks, MD, PhD,b
Ewald C. Bollen, MD, PhD,a Martin H. Prins, MD, PhD,b and Joep A.W. Teijink,a Heerlen and
Maastricht, The Netherlands
Objective: This study describes the results and functioning of community-based supervised exercise therapy (SET) at one
year of follow-up.
Methods: We conducted a prospective cohort study of community-based SET in regional physiotherapeutic practices.
Consecutive patients with intermittent claudication referred for community-based SET were included. Exclusion criteria
for SET were pain at rest or tissue loss. All patients received a diagnostic workup consisting of an ankle-brachial index at
rest and after exercise. Interventions were exercise therapy according to the guidelines of the Royal Dutch Society for
Physiotherapy. The primary outcome measurement was the increase in absolute claudication distance (ACD), assessed
using a standardized treadmill protocol by a physiotherapist at baseline and at four, 12, 26, and 52 weeks of SET.
Results: From January 2005 through September 2006, 349 patients were referred by vascular surgeons for community-
based SET. A total of 272 patients with intermittent claudication began the program. Of the 349 initially referred
patients, 52 could not perform a standard treadmill test but did start community-based SET at a lower level, and 25
patients never started the program. At one year, 129 of the original 272 patients who began community-based SET
(47.4%) were available for analysis of walking distance. In the interim, 143 patients discontinued the program for the
following reasons: satisfaction with the acquired walking distance (n  19); unsatisfying results (n  26); not motivated
(n  22); (non)vascular intercurrent disease (n  48); and other reasons (n  28). ACD increased significantly from a
median of 400 m at baseline to 1100 m after 12 months of follow-up (P < .001), corresponding to a median increase of
107.8%.
Conclusion:Community-based SET seems as effective as SET in a hospital-based approach in improving walking distance,
however, it has a high dropout rate. ( J Vasc Surg 2009;49:363-70.)Intermittent claudication is a common symptom in
patients with peripheral arterial disease (PAD). Treatment
of patients suffering from intermittent claudication is based
on two basic components: treatment of vascular risk factors
to prevent future vascular events and treatment of symp-
toms.1 Symptomatic relief of complaints of intermittent
claudication can be achieved by exercise therapy, percuta-
neous transluminal angioplasty (PTA), and surgical revas-
cularization. Exercise therapy is efficacious in improving
walking distance2 and is considered the first choice of treat-
ment (Fontaine stage II). However, in cases of more proximal
disease (eg, aortic or iliac), primary revascularization is ad-
vised.1
The most common exercise therapy prescription con-
sists of one-time oral advice to walk more, usually without
supervision or follow-up.3 However, the importance of
supervised exercise therapy (SET) is increasingly recog-
nized.1,4 A recent Cochrane review reported a significant
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Vascular Surgery.doi:10.1016/j.jvs.2008.09.042difference in favor of SET compared with an unsupervised
exercise program in improving walking distance.5 Trials
included in this review provided SET programs at a depart-
ment of physiotherapy or revalidation in a hospital. While
this approach is appropriate in trials, there are some limita-
tions in routine clinical practice. First, the capacity of a
single department in a hospital is limited and not sufficient
to provide SET to all claudication patients in the commu-
nity. Second, attending at the hospital for two or three
times a week is time consuming and expensive for the
patient. These pitfalls can be solved using a community-
based approach to SET,6 consisting of a selected group of
community-based physiotherapists especially trained in ap-
plying exercise therapy. Implementation of community-
based SETwas first described byWilligendael et al,7 and the
first results in a selected group of patients were promising.8
This study describes the results of community-based
SET at one year of follow-up comparedwith clinic-based SET
with results known from literature. Furthermore, we give a
status report on how community-based SET works in daily
practice and describe the possible pitfalls of this approach.
PATIENTS AND METHODS
Study setting. All patients presenting at the vascular
outpatient clinic with complaints of intermittent claudica-
tion receive a diagnostic workup consisting of an ankle
brachial index (ABI) measurement, which, if below 0.9,
was followed by duplex ultrasound of the aortic-iliac tract.
Patients with occlusive disease of the aortic-iliac tract were
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tion in the same procedure. Patients with more distal
disease were primarily considered for community-based
SET and referred to a physiotherapist participating in the
Network for Exercise Therapy Parkstad (NETP). The
NETP provides community-based SET in private physio-
therapy practices equally distributed over the region, in-
stead of a department of physiotherapy and rehabilitation in
a hospital or rehabilitation clinic. All participating physio-
therapists are trained according to the guidelines of the
Royal Dutch Society for Physiotherapy (Table I).9 Training
of physiotherapists, and the development and implementa-
tion of the NETP is described in more detail by Willigen-
dael et al.7
All patients with confirmed PAD received a platelet
inhibitor and lipid-lowering medication. Diabetes mellitus
and hypertension were treated according to current guide-
lines. Furthermore, smoking cessation and lifestyle advice
were part of a cardiovascular prevention program initiated
by a team of vascular nurse practitioners.
Study population. All consecutive patients referred
for community-based SET from January 2005 through
September 2006 were included. Patients with complaints
of intermittent claudication were eligible for community-
based SET after confirmation of PAD with an ABI mea-
surement below 0.9 at rest or decreasing more than 0.15
after exercise. Signs of critical ischemia (eg, pain in rest,
tissue loss) were exclusion criteria for participating in
community-based SET.
Exercise program. All participating physiotherapists
were participating in the NETP, a community-based pro-
gram for SET in patients with intermittent claudication.
SET was administered according to the guidelines of the
Royal Dutch Society for Physiotherapy.9 The main goal of
SET is to increase absolute claudication distance (ACD),
the distance at which severe claudication pain forces cessa-
tion of exercise. This goal was achieved by means of interval
Table I. Summary of the Royal Dutch Society for Physiot
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Education Course in ex
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Fontaine clas
risk and ca
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Patient Sp
ACSM, American College of Sports Medicine; SET, supervised exercise thetraining with treadmill walking up to (sub)maximal pain.Secondary goals are improving endurance, increasing
strength, and correcting walking patterns.
Generally, patients started with a frequency of two to
three sessions every week of approximately 30 minutes in
the first three months. After this initial phase, the frequency
was phased down to approximately once every two weeks at
six months of follow-up and once every eight weeks at 12
months of follow-up, depending on patient progress and
preference. Patients were encouraged to walk on a daily
basis to near maximal pain. Furthermore, all participating
physiotherapists were instructed to emphasize as much as
possible the importance of lifestyle adjustments and smok-
ing cessation.
In The Netherlands, intermittent claudication is one of
the chronic diseases that is considered for physiotherapy
during the period of one year. Therefore, for every patient,
from the tenth session through the period of one year,
reimbursement is financed by the National Insurance of
Health Care. Reimbursement for the first nine sessions of
30 minutes of exercise therapy depends on the patient’s
additional and voluntarily health insurance. The minimal
advised charge of one session of physiotherapy is 32.07
USD (www.fysionet.nl). Approximately, the mean costs of
one year of community-based SET lie in between 801.75
and 1282.80 USD, dependant on the frequency of the
sessions.
Therapy evaluation. Patients were evaluated by their
physiotherapist at baseline and at four, 12, 26, and 52
weeks of follow-up. Patients performed a standardized
treadmill test, and their physiotherapists registered walking
distances and possible reasons for dropping out of the SET
program. A progressive treadmill test was used, with a
constant speed of 3.2 km/h and an increase in incline of 2%
every two minutes, starting at 0% incline.10 The incline and
testing duration were maximized for practical reasons to
10% and 30 minutes (1600 m), respectively.
Outcomes of these evaluations were registered in a
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tion; Ankle-Brachial Index (0.9); Walking impairment; Cardiac
y; Contra-indications
o-morbidities; Patient specific complaints scale
o-morbidities
ill test; Gait and specific function analysis
walking distance; Increase aerobe endurance; Increase pain
duce fear of pain; Improve gait and specific activities (stair
rovide information and induce life style changes
ance; Reduce fear of pain; Induce active life style and improve
xercise therapy; Life style
up to (sub)maximal pain; At least 6 months; At least 30 minutes
lking 3 times a week (supervised or homework)
ation; Extensive evaluation at least after four and 12 weeks;
ill test, Borg Ratings of Perceived Exertions; ACSM pain scale;
Complaints Scalehera
ycle e
ercise
sifica
pacit
fic; C
fic; C
eadm
imum
nd re
etc); P
toler
fic; E
lking
; Wa
evalu
readm
ecificWeb-based electronic patient file, available for the physio-
JOURNAL OF VASCULAR SURGERY
Volume 49, Number 2 Kruidenier et al 365therapist as well as the vascular surgeons and nurse practi-
tioners (www.fastguide.eu).
Outcome measurements. The primary outcomemea-
surement was the percentage increase in ACD. Secondary
outcome measurements were functional claudication dis-
tance (FCD), defined as the distance at which the patient
prefers to stop because of claudication pain, and the num-
ber of invasive vascular interventions within one year after
starting community-based SET.
Furthermore, results were categorized as good, mod-
erate, or unsatisfactory according to an objectively mea-
sured increase in ACD and according to the dropout reason
of a patient. If patients stated that they were not satisfied
with the walking distance at time of dropout, the result was
classified as unsatisfactory. If patients stated that the reason
of dropout was satisfaction with the regained walking dis-
tance, the result was classified as good.
Analysis. All interval and ratio variables are presented
as median and inter-quartile-range (IQR) because most
variables were not normally distributed.Means are reported
to allow comparison of the results of this study with results
from the literature. Nominal variables are presented as
absolute numbers and percentages.
For every patient, the percentage increase in FCD and
ACD compared with baseline was calculated. Exclusion
criteria for analysis of walking distances were the absence of
a baseline measurement or the inability to walk according
to the standardized treadmill protocol. All other patients
were included in the analysis when data were available. The
statistical significance of this within-group difference was
analyzed with a Wilcoxon signed-ranks test.
Results were categorized as good, moderate, or unsat-
isfactory.9 A good result was defined as an increase of 100%
or more in ACD or dropping out of SET because of
satisfaction with the regained walking distance. A moderate
result was defined as an increase in ACD between 50% and
100%. The result was defined as unsatisfactory in cases of an
ACD increase of less than 50% or dropping out of SET
because of patient dissatisfaction with the acquired walking
distance. In patients undergoing a vascular intervention
during the year, the last result before the vascular interven-
tion was carried forward. In addition, the last result before
dropping out for reasons other than (dis)satisfaction was
carried forward.
Statistically significant differences between groups were
calculated with a Mann-Whitney U test for ordinal and
interval variables and a 2 test for binominal variables. If
criteria for a 2 test were not fulfilled, a Fisher exact test was
used. Comparison of more than two groups was performed
using a 2 test for trend. A value of P .05 was considered
to be statistically significant. Analyses were performed using
SPSS 12.0 for Windows (SPSS, Inc, Chicago, Ill).
RESULTS
From January 2005 through September 2006, 349
patients with intermittent claudication were referred for
community-based SET. Baseline characteristics of this pop-
ulation are summarized in Table II. Fifty-two patients werenot able to perform a standard treadmill test as described
above and were excluded from further analysis. These pa-
tients did start community-based SET but at a lower level.
Twenty-five patients never started community-based SET
for various reasons (Fig 1). These patients were also ex-
cluded from further analysis.
A total of 272 patients with intermittent claudication
started community-based SET. At one year, 129 patients
(47.4%) were available for analysis of walking distance (Fig
1). The remaining 143 patients discontinued the program
for the following reasons: satisfaction with the acquired
walking distance (n  19); unsatisfying results (n  26);
not motivated (n 22); (non)vascular intercurrent disease
(n  48); and other reasons (n  28). No differences in
baseline characteristics were found between withdrawals and
the population that completed 12 months of community-
based SET, with the exception of the greater number of
current smokers (P  .046) in the withdrawal group
(Table II).
Walking distances. The median FCD and ACD at
baseline were 230.0 m (mean, 325.0 m) and 400.0 m
(mean, 493.1 m), respectively. After 12 months of follow-
up, the median walking distances significantly increased to
700.0 m (mean, 867.0 m) for FCD and 1100.0 m (mean,
1053.5 m) for ACD (P .001). This increase corresponds
to a median increase of 166.7% (mean, 279.3%) and 107.8%
(mean, 196.9%) compared with baseline for FCD and ACD,
respectively. Notably, most of the increase in walking distance
occurred in the first sixmonths of community-based SET.No
further improvement inwalking distancewas seen between six
and 12 months of follow-up.
Table III shows more details about the different walk-
ing distances at four, 12, and 26 weeks of follow-up.
Course of response to SET. The results of the total
cohort (n  272) were categorized as good, moderate, or
unsatisfactory. Because of the chosen definitions, 37 pa-
tients could not be classified. Of these, 33 dropped out
before the first follow-up measurement, and four patients
had a vascular intervention before four weeks of follow-up,
resulting in 235 patients who were available for analysis.
The clinical course of the cohort is graphically repre-
sented in Fig 2, in which the size of the arrows reflects the
number of patients. As Fig 2 shows, after 52 weeks of
follow-up or at the moment a patient dropped out, 112
patients (47.7%) showed a good result, 38 (16.2%) had a
moderate result, and 85 (36.2%) had an unsatisfactory
result. Good or unsatisfactory results achieved at 12 weeks
of follow-up were likely to persist at 26 and 52 weeks of
follow-up.
Vascular interventions. Out of 272 patients, 43 had a
vascular intervention within the follow-up period of one
year, of whom 33 received a PTA, six had bypass surgery,
and four had other vascular interventions. In 39 patients
(90.7%), the indication was intermittent claudication, and
in four patients (9.3%), it was critical limb ischemia.
The distribution of the interventions in the different
result categories showed a non-significant trend in those
with an unsatisfactory result. The frequency of interven-
dy ma
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groups showing moderate and unsatisfactory results, these
percentages were 13.2% and 25.9%, respectively.
Additional observations. Fifty-two patients were not
able to walk at the speed of 3.2 km/h of the standardized
treadmill protocol. In general, these patients had poorer
clinical characteristics; they were older (P  .001), had
diabetes more often (P  .014), and had a significantly
lower resting ABI (P .008) than patients starting the usual
community-based SET. However, these 52 patients started
community-based SET at their own level, with varying speeds
and inclines during treadmill testing. Another striking differ-
ence between the group starting community-based SET at a
low level and the group starting the usual SET was the
dropout percentage. In the low level group, the dropout rate
was 84.6% compared with 52.5% in the standard SET group
(P .001).
Seven patients from the lower-level group had a vascu-
lar intervention, all for intermittent claudication; four of
these patients had PTA, and three had bypass surgery. This
outcome was not significantly different from the standard
Table II. Demographic and clinical characteristics
Characteristic
Total population,
n  349
Age (years) 66.0 (58.6-74.0)
Men 219/349 (62.8%)
BMI 26.1 (23.6-29.0)
n  331
Resting ABI 0.70 (0.60-0.88)
n  342
Current smokers 168/341 (49.3%)
Hypertension 266/349 (76.2)
Diabetes mellitus 117/349 (33.5%)
Hypercholesterolemia 267/349 (76.5%)
Coronary heart disease 93/349 (26.6%)
Cerebrovascular disease 47/349 (13.5%)
COPD 50/349 (14.3%)
Arthrosis 19/349 (5.4%)
Previous vascular intervention 113/349 (32.3%)
Systolic blood pressure (mmHg) 150.0 (135.0-170.0)
Systolic blood pressure (mmHg) n  344
Glucose (mmol/l) 5.9 (5.3-7.1)
n  330
HbA1C (%) 6.0 (5.8-7.1)
n  238
Cholesterol (mmol/l) 5.2 (4.2-6.0)
n  333
HDL (mmol/l) 1.33 (1.12-1.60)
n  316
LDL (mmol/l) 2.8 (2.0-3.5)
n  304
Triglycerides (mmol/l) 1.60 (1.11-2.22)
n  311
FCD (m) 230.0 (120.0-427.5)
n  269
ACD (m) 400.0 (323.0-630.8)
n  272
ABI, Ankle-brachial index; ACD, Absolute claudication distance; BMI, Bo
claudication distance; NS, Not significant.SET group.Twenty-five patients never started community-based
SET for different reasons (Fig 1). Within one year after
referral, three patients received a PTA and one patient
received another vascular intervention. This outcome was
not significantly different from the number of interventions
in the group starting community-based SET. Patients never
starting community-based SET were more likely to be men
(P  .012) compared with patients who did start SET.
There were no other significant differences between these
two groups.
DISCUSSION
In this study, we have shown that one year of community-
based SET results in highly significant increases in FCD as
well as ACD after four, 12, 26, and 52 weeks of follow-up.
However, community-based SET has a high dropout rate.
These results for walking distance as well as for dropout are
in line with the results after six months of community-based
SET published recently by Bendermacher et al.8 Most
reports on SET for patients with intermittent claudication
are situated in an outpatient clinical setting, but these also
opulation completing
12 months, n  137
Withdrawals,
n  212 P value
66.4 (58.6-73.7) 65.7 (58.5-74.3) NS
8/137 (64.2%) 131/212 (61.8%) NS
26.6 (23.9-29.4) 25.9 (23.1-28.9) NS
n  136 n  195
0.71 (0.60-0.88) 0.70 (0.60-0.88) NS
n  135 n  207
8/136 (42.6%) 110/205 (53.7%) .046
3/137 (75.2%) 163/212 (76.9%) NS
8/137 (35.0%) 69/212 (32.5%) NS
9/137 (79.6%) 158/212 (75.4%) NS
5/137 (25.5%) 58/212 (27.4%) NS
3/137 (9.5%) 34/212 (16.0%) NS
2/137 (16.1%) 28/212 (13.2%) NS
7/137 (5.1%) 12/212 (5.7%) NS
5/137 (32.8%) 68 (32.1%) NS
150.0 (135.0-172.3) 150.0 (132.3-170.0) NS
n  136 n  208
5.9 (5.2-7.1) 5.9 (5.3-7.0) NS
n  127 n  203
6.2 (5.8-7.2) 6.0 (5.7-6.9) NS
n  94 n  144
5.1 (4.3-6.0) 5.2 (4.1-5.9) NS
n  130 n  203
1.35 (1.12-1.67) 1.31 (1.09-1.58) NS
n  123 n  193
2.6 (2.1-3.5) 2.9 (2.0-3.6) NS
n  119 n  185
1.52 (1.08-2.42) 1.67 (1.13-2.22) NS
n  122 n  189
260.0 (130.0-450.0) 205.0 (117.0-382.5) NS
n  127 n  142
276.0 (450.0-689.0) 370.0 (207.0-590.0) NS
n  129 n  143
ss index; COPD, Chronic obstructive pulmonary disease; FCD, FunctionalP
8
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4show comparable results in improving walking dis-
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clinic-based SET after six and 12 months of follow up.2,5
The overall mean percentages increase of clinic-based SET
after six and 12 months of follow up are 92% and 108%,
respectively. In our study, we found median increases in
ACD of 88% (mean, 191%) and 108% (mean, 197%) after
six and 12 months of follow up, suggesting community-
based SET is as least equal to clinic-based SET.
Furthermore, an interesting observation is that a good
or unsatisfactory result achieved after three months of
community-based SET was unlikely to have changed at six
and 12 months. This finding could have consequences for
clinical care and could lead to the notion that if results are
unsatisfactory at three months of community-based SET,
Fig 1. Flow chart of the total population referred for community-
based supervised exercise therapy. ACD, Absolute claudication
distance.other treatment options should be considered. Naturally, atthat time, severity of complaints and the risk of invasive
interventions must be taken into account.
Patients referred for community-based SET are offered
one year of exercise therapy, based on limited reimburse-
ment up to one year. However, after six months of SET,
walking distance had stabilized and FCD and ACD did not
increase further. The reason for this phenomenon is un-
clear. A possible explanation is that after six months of
community-based SET, patients achieve their maximum,
entering into a plateau phase. Another explanation could
be that within a year of community-based SET, the fre-
quency of sessions gradually decreases, leading to mainte-
nance of but not increases in walking distance. In a meta-
analysis by Gardner et al, the best duration of a SET
program was six months or longer, but no distinction was
made between six and 12 months.21 Dose-response re-
search is needed to address this issue.
Another issue of discussion is the mode of exercise.
Currently, the recommended mode of exercise mainly con-
sists of treadmill walking to near maximal pain, according
to the guidelines of the Royal Dutch Society for Physio-
therapy.9 However, recent research suggests that a pain-
free mode of training also has significant effects on
walking distance compared with a non-exercising con-
trol group.22,23 Possible advantages of pain-free training
could be better compliance and lower dropout rates. To
determine if pain-free walking is as effective as walking to
near maximal pain, further research is needed.
Comparing non-supervised exercise therapy with SET,
the results with SET are statistically significantly better,
leading to approximately 150-m and 225-m greater in-
creases in ACD after three months5 and six months24 of
follow-up, respectively. Ideally, according to the Trans-
Atlantic Inter-Society Consensus Document on manage-
ment of PAD (TASC-II), SET should be made available for
all patients with intermittent claudication.1 Implementing
SET for intermittent claudication in an outpatient clinic,
however, is very complicated or maybe even impossible,
based on its disadvantages. First of all, the capacity of the
usual department of rehabilitation and physiotherapy in a
hospital is not sufficient for the numbers of patients with
intermittent claudication who are eligible for non-invasive
therapy. Furthermore, patients are often limited in their
transport to the hospital in terms of costs and time.
Community-based SET is an easy and good alternative for
structurally implementing SET for every patient with inter-
mittent claudication.
In addition to the effects on walking distance, SET
could have a beneficial effect related to vascular risk factor
management. Exercise has a known positive influence on
vascular risk factors such as hypertension, hypercholester-
olemia, and diabetes mellitus.25 Furthermore, reports show
that patients with PAD26 (or more specifically, intermittent
claudication)27 who are physically active are less likely to die
compared with a group of sedentary patients with
PAD.26,27 After adjustments for age, ABI, and body mass
index, these results are similar in patients with intermittent
claudication.27
ce.
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could be the large number of participating physiotherapists,
leading to a lower volume of patients and less experience
per physiotherapist. Thus, by referring patients only to
specifically trained physiotherapists and not to just any
physiotherapist, this problem can be addressed. Further-
more, by organizing SET in a community-based setting,
an increasing number of patients with intermittent clau-
dication can be treated, leading to greater numbers of
experienced physiotherapists. In addition, regular re-
fresher courses with all participating physiotherapists can
Table III. Walking distances
Follow up N Median (IQR) M
Median increase functional claudication distance*
Baseline 269 230.0 (120.0-427.5)
1 month 201 412.0 (275.0-630.0)
3 months 187 510.0 (324.0-840.0)
6 months 159 650.0 (350.0-1200.0)
12 months 125 700.0 (395.0-1600.0)
Median increase absolute claudication distance
Baseline 272 400.0 (232.0-630.8)
1 month 206 618.5 (407.5-985.0)
3 months 190 792.0 (487.5-1242.5)
6 months 163 900.0 (490.0-1600.0)
12 months 129 1100.0 (520.0-1600.0)
IQR, Interquartile range.
*In some patients, only absolute claudication distance was measured.
(37.0%)
result
(17.4%)
(37.9%)
result
Fig 2. Clinical course of the total cohort. The arrow
categories in time and the blocks indicate the results at the
blocks reflect the number of patients. Green, blue, and re
result respectively. Good result: increase in ACD of100
result: increase in ACD50% and100%. Unsatisfactor
the walking distance. ACD, Absolute claudication distanensure adequate and shared knowledge. However, thenumber of referred patients, and thus the experience of
the physiotherapists, is dependant on the utilization of
the program.
The high number of dropouts (40.0% within six
months and 52.6% within 12 months) is a disadvantage of
community-based SET. However, in the literature, we find
corresponding dropout percentages after six months of
SET, from 10% up to 50%.17,22,28-30 Only two studies
report a dropout percentage after 12 months, ranging from
16% to 41%.15,31 It should be realized that in the literature,
dropout is observed in randomized controlled trials that
Absolute median increase
(IQR) m
Median % increase (IQR)
percentage
— —
110.0 (30.0-245.0) 47.7% (8.3-115.6)
220.0 (90.0-430.0) 100.0% (34.5-260.9)
340.0 (143.0-747.0) 140.0% (59.1-380.0)
440.0 (172.0-905.0) 166.7% (79.4-342.2)
— —
140.0 (40.0-330.0) 37.1% (10.5-77.6)
265.0 (110.0-592.5) 79.4% (33.9-169.0)
360.0 (149.0-850.0) 87.5% (33.3-229.2)
506.0 (185.5-890.0) 107.8% (47.8-201.9)
(42.1%)
(47.7%)
(17.9)
(36.2%)
(16.2%)
(36.2%)
resent movement of patients between different result
rent follow-upmeasurements. The size of the arrows and
esent patients with a good, moderate, and unsatisfactory
patient satisfaction with the walking distance. Moderate
lt: increase in ACD50% or patient dissatisfaction withs rep
diffe
d repr
% or
y resuhave a highly selected patient population with strictly cho-
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rates of community-based SET in usual practice seem not
to be increased compared with clinic-based SET.
Although the presence of intermittent claudication
leads to functional impairment for the patient, the clinical
course as far as the leg is concerned is surprisingly stable in
most cases.1 For this reason, it is usually acknowledged that
invasive interventions with known morbidity and mortality
should be used with restraint. The main reason for patients
to stop community-based SET is intercurrent disease, and
not unsatisfactory results. Thus, if a patient stops SET, the
reason should be evaluated. The physician can use this
moment to evaluate to the next level of decision making
and consider an invasive intervention, if clinically indicated.
Our data suggest that after three months of SET, a physi-
cian can properly evaluate a patient’s response to SET. In
summary, SET represents a viable treatment for intermit-
tent claudication with no known complications and has the
potential to treat patients safely, preventing an invasive
vascular intervention in a number of patients. Although
many patients discontinue SET prematurely, its non-
invasive nature and satisfactory improvement in the major-
ity of patients are reasons to use it as the initial treatment in
patients with intermittent claudication. In case of unsatis-
factory results, the option for PTA or surgical revascular-
ization is still open if clinically indicated.
CONCLUSION
Community-based SET seems as efficacious as SET in a
clinical study approach in improving walking distance in
patients with intermittent claudication, however, has high
dropout rates. Furthermore, good and unsatisfactory re-
sults after three months are likely to persist, which could be
useful for a physician in evaluating response to community-
based SET and planning further treatment.
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